Lucy Cureton

Clinical Trial Manager for COVID-19 treatment trials: ATOMIC2 (Azithromycin in ambulatory COVID patients) and AVID-CC (Adalimumab for COVID patients in care home settings).

I joined NDORMS in October 2016 as a Clinical Trial Manager for the GRASP trial within the RRIO team. The end of the GRASP trial coincided with the onset of the pandemic, which is when I moved over the Experimental Medicine and Rheumatology (EMR) group to manage COVID treatment trials.

Prior to joining NDORMS, I worked as a Study Administrator on a number of large CTIMPs for the Nuffield Department of Population Health.

Originally from Coventry, I attended Oxford Brookes University where I achieved a BSc in Biology and have lived locally in Oxford ever since.